A Phase 2/3 interventional study of intestinal fluid infusion and potable water in Low Anterior Resection Syndrome and Rectal Cancer, sponsored by Pei-Rong Ding. Recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-04-17.
Sponsored by Pei-Rong Ding · Phase 2/3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Low Anterior Resection Syndrome with a site in China — 7 open to participants now, 9 under way, 1 of them phase 3. Low Anterior Resection Syndrome · China.
Among the 13 studies in Low Anterior Resection Syndrome with a site in China, this one is the 4th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is the only one in phase 2/3, and was the 11th registered.
82 studies on the registry are indexed under Low Anterior Resection Syndrome; 38 are open to participants now.
Browse Low Anterior Resection Syndrome studies →7 of the 13 studies in Low Anterior Resection Syndrome with a site in China are open now. Recruiting first, the newest first:
Northern Jiangsu People's Hospital · Sites in China
Ages 18–80
Sixth Affiliated Hospital, Sun Yat-sen University · Sites in China
Ages 18–75
The Affiliated Hospital of Qingdao University · Sites in China
Ages 18–85
Sixth Affiliated Hospital, Sun Yat-sen University · Sites in China
Ages 18–75
Qilu Hospital of Shandong University · Sites in China
Ages 18–75
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 25 Low Anterior Resection Syndrome studies recruiting now, 17 (68%) set no upper age limit and 4 (16%) stop at 75 or younger; none take children under 18; 2 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 1
First in 2015; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 160 is above the median of 72 across 56 interventional studies indexed under Low Anterior Resection Syndrome.
Median enrollment 146 across the 10 interventional studies, 261 across the 3 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 9 most frequent:
Pei-Rong Ding is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Pei-Rong Ding has 1 study filed under Low Anterior Resection Syndrome — fewer than ten, so there is no comparison to draw.
4 of the studies in Low Anterior Resection Syndrome with a site in China that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07537998Phase 3Pei-Rong DingAntegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial. | 2027-04-10 |
| NCT06717854Sichuan Cancer Hospital and Research InstituteRetrograde and Antegrade Enema for Prevention of LARS After LAR: a Randomized Controlled Trial | 2026-12-30 |
| NCT07071987Northern Jiangsu People's HospitalEffect of Thread Embedding Acupuncture on Postoperative Ileus Recovery After Colorectal Cancer Surgery: A Multicenter Randomized Controlled Trial | 2027-07-31 |
| NCT05943444Sixth Affiliated Hospital, Sun Yat-sen UniversityComparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer | 2027-08-08 |
Add all 4 to your calendar (.ics) → With an account.
Among the 13 studies in Low Anterior Resection Syndrome with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if antegrade intestinal fluid reinfusion works to prevent low anterior resection syndrome (LARS) in patients with prophylactic ileal stoma. The main questions it aims to answer are:
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Starting from 4 weeks after the DIXON + ileostomy surgery until the day before the ileostomy reversal surgery, the patient was instructed on enema procedures by enterostomal therapist after being enrolled in the study. After preparing the autologous intestinal fluid, it is diluted with warm saline to a volume of 200-500 ml. It is then returned through the distal end of the ileal stoma in a retrograde manner, once every other day.
Combination Product: intestinal fluid infusion
Starting from 4 weeks after the DIXON + ileostomy surgery until the day before the ileostomy reversal surgery, the patient was instructed on enema procedures by enterostomal therapist after being enrolled in the study. Prepare 200-500 ml of potable water, and then infuse it antegradely from the distal end of the ileal stoma, once every other day.
Combination Product: potable water
Prepare autologous intestinal fluid and perform rantegrade reinfusion from the distal end of the stoma.
Infuse potable water through the distal end of the stoma.
LARS score(m1)
Improvement in LARS score 1 month after ileostomy reversal surgery between the two group. Low Anterior Resection Syndrome Score (LARS Score) is a validated specific score for low anterior resection syndrome which ranges from 0 points (normal - best score) to 42 point (LARS major - worst score).
Time frame: 1 month after ileostomy reversal surgery
Major LARS rate(m1)
Major LARS rate 1 month after ileostomy reversal
Time frame: 1 month after ileostomy reversal
LARS score (m0-12)
Trajectory of change of LARS score after ileostomy reversal surgery in the two group. Low Anterior Resection Syndrome Score (LARS Score) is a validated specific score for low anterior resection syndrome which ranges from 0 points (normal - best score) to 42 point (LARS major - worst score).
Time frame: 2 weeks, 1 month, 2 months, 3 months, 6 months and 12 months after ileostomy reversal surgery
MSKCC BFI
Memorial Sloan Kettering Cancer Centre Bowel Function Instrument
Time frame: 2 weeks, 1 month, 2 months, 3 months, 6 months and 12 months after ileostomy reversal surgery
Wexner score
The Wexner scoring system is a clinical tool used to assess the severity of constipation. Mainly used to quantify the constipation symptoms of patients and their impact on their quality of life. Including five aspects: defecation frequency, difficulty in defecation, emptying sensation, abdominal pain, and time spent in the toilet. The total score range is 0-25 points. A score below 7 points is considered mild constipation, 7-15 points is moderate constipation, and above 15 points is severe constipation.
Time frame: 2 weeks, 1 month, 2 months, 3 months, 6 months and 12 months after ileostomy reversal surgery
quality of life for rectal cancer patients
quality of life will be measured using the EORTC Colorectal Cancer Module QLQ-CR29 (EORTC QLQ-CR29 )
Time frame: 2 weeks, 1 month, 2 months, 3 months, 6 months and 12 months after ileostomy reversal surgery
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Apr 2026; primary completion for Apr 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Low Anterior Resection Syndrome →